Insurance AI Model Risk Management Build vs. Buy | Moring
For insurers deciding whether to build or buy model risk management capability, the decisive fact is accountability: carriers answer for every AI decision even when the model came from a vendor. Buy accelerates coverage; build protects proprietary underwriting and claims logic. Most insurers need a hybrid governed by tiered risk.
Short answer
For insurers deciding whether to build or buy model risk management capability, the decisive fact is accountability: carriers answer for every AI decision even when the model came from a vendor. Buy accelerates coverage; build protects proprietary underwriting and claims logic. Most insurers need a hybrid governed by tiered risk.
How it works
Build-versus-buy questions in insurance model risk management start from an uncomfortable premise: the carrier is responsible for every AI-driven decision whether the model was built internally or sourced from a vendor. That principle, echoed in insurance-specific governance guidance and in the NAIC's work on insurer use of artificial intelligence, means that buying a model does not buy out of model risk. The decision is about where to invest scarce governance capacity, not about who holds the risk.
Buying tends to win where the risk is generic. Third-party scoring engines, claims document processing, and commodity forecasting come with vendor documentation, independent validation packages, and product update cycles that an internal team would have to replicate. Procurement can then focus diligence on the vendor's evidence: conceptual soundness, performance testing, monitoring commitments, and the contractual right to audit. For high-volume, low-differentiation models, a purchased capability with strong assurance artifacts is often the lower-risk option.
Building tends to win where the model embodies proprietary judgment. Pricing sophistication, loss reserving, and fraud patterns tied to a carrier's own book are competitive assets, and outsourcing them dilutes both the advantage and the understanding. Internal development also keeps validation in-house: the model risk function can see training data lineage, feature choices, and assumption sets directly, rather than reconstructing them from a vendor package. The trade is cost and speed for depth of control.
Either path converges on the same governance obligations. Under the EU AI Act, obligations attach to the role an organization plays, provider or deployer, and insurers deploying third-party high-risk systems still carry deployer duties such as monitoring and human oversight. A purchased model therefore needs the same tiering, approval, monitoring, and evidence discipline as a built one; only the division of labor changes. Vendor risk management becomes a standing input to model validation rather than a separate process.
A practical hybrid works well for most carriers. Buy the platform layer: model inventory, monitoring, drift detection, and evidence capture, where scale matters and differentiation does not. Build the judgment layer: proprietary pricing, underwriting, and claims models, wrapped in the carrier's own validation and approval gates. This split matches how insurance leaders actually describe the problem, controlling risk across the lifecycle while preserving the models that differentiate the book.
The residual risk of the hybrid is integration: a bought platform governing built models can create evidence gaps at the seams. Close them by requiring the same inventory records, approval trail, and monitoring output from both paths, and by validating vendor tooling itself as part of the model risk program.
Frequently asked questions
Does buying a model from a vendor reduce an insurer's model risk?
No. Insurance governance guidance is explicit that carriers are responsible for every AI-driven decision even when the model came from a vendor. Buying shifts development work, not accountability. The insurer still has to tier the model, validate it, monitor it in production, and retain evidence, and vendor diligence becomes an input to that model risk process rather than a substitute for it.
When should an insurance carrier build rather than buy a model?
Build when the model embodies proprietary judgment: pricing sophistication, loss reserving, or fraud patterns tied to the carrier's own book. Internal development keeps training data lineage, feature choices, and assumptions visible to the model risk function, which makes validation deeper. For commodity scoring or document processing where differentiation is low and vendors provide strong assurance packages, buying is usually the lower-risk, faster option.
How does the EU AI Act affect the build-versus-buy decision for insurers?
The EU AI Act attaches obligations to roles, so an insurer deploying a purchased high-risk system still carries deployer duties such as human oversight, monitoring, and logging. That means the buy option does not remove compliance work; it changes who performs which task. Insurance carrier governance should require the same tiering, approval, and evidence standards for bought and built models alike.
What is the best hybrid structure for insurance model risk management?
Buy the platform layer, including model inventory, monitoring, drift detection, and evidence capture, where scale matters more than differentiation. Build the judgment layer: proprietary pricing, underwriting, and claims models wrapped in the carrier's own validation and approval gates. Then close the integration seams by requiring identical inventory records across the model risk program, approval trails, and monitoring output from both built and bought components.